Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey

Japanese Journal of Infectious Diseases

Volumn 61, Issue 4, 2008, Pages 255-260

  Aslan, Gonul ^a   Tezcan, Seda ^a   Serin, Mehmet Sami ^a   Emekdas, Gurol ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; ISONIAZID; KATG PROTEIN; NUCLEOTIDE; PROTEIN INHA; REGULATOR PROTEIN; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; SERINE; THREONINE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CODON; CONTROLLED STUDY; DNA SEQUENCE; DRUG SENSITIVITY; GENE INSERTION; GENE LOCUS; GENE MUTATION; GENOTYPE; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; TURKEY (REPUBLIC);

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; CODON; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; POLYMERASE CHAIN REACTION; RIFAMPIN; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; TURKEY;

EID: 48849083996     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mukherjee, J.-S., Rich, M.-L., Socci, A.-R., et al. (2004): Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet, 363, 474-481.
2. Simon, S. and Listiawan, I. (2003): Drug resistance in Mycobacterium tuberculosis: a molecular perspective. Madjalah Kedokt. Indones., 4, 26-35.
3. Bakonyte, D., Baranauskaite, A., Cicenaite, J., et al. (2003): Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. Antimicrob. Agents Chemother., 47, 2009-2011.
4. Somoskovi, A., Parsons, L.-M. and Salfinger, M. (2001): The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir. Res., 2, 164-168.
5. Rossau, R., Traore, H., Beenhouwer, H.-D., et al. (1997): Evaluation of the INNO-Lipa Rif. Tb assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob. Agents Chemother., 41, 2093-2098.
6. Hillemann, D., Weizenegger, M., Kubica, T., et al. (2005): Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol., 43, 3699-3703.
7. Ramaswamy, S. and Musser, J.-M. (1998): Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis., 79, 3-29.
8. Ahmad, S. and Mustafa, A.-S. (2001): Molecular diagnosis of drug-resistant tuberculosis. J. Kuwait Med. Assoc., 33, 120-126.
9. Sajduda, A., Brzostek, A., Poplawska, M., et al. (2004): Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland. J. Clin. Microbiol., 42, 2425-2431.
10. Gillespie, S.-H. (2002): Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob. Agents Chemother., 46, 267-274.
11. Ozturk, C.-E., Sanic, A., Kays, D., et al. (2005): Molecular analysis of isoniazid, rifampin and streptomycin resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Duzce, Turkey. Jpn. J. Infect. Dis., 58, 309-312.
12. Cardoso, R.-F., Cooksey, R.-C., Morlock, G.-P., et al. (2004): Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob. Agents Chemother., 48, 3373-3381.
13. Zhang, M., Yue, J., Yang, Y.-P., et al. (2005): Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J. Clin. Microbiol., 43, 5477-5482.
14. Bang, D., Andersen, A.-B. and Thomsen, V.-Ø. (2006): Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens. J. Clin. Microbiol., 44, 2605-2608.
15. Cavusoglu, C., Hilmioglu, S., Guneri, S., et al. (2002): Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J. Clin. Microbiol., 40, 4435-4438.
16. Telenti, A., Imboden, P., Marchesi, F., et al. (1993): Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet, 341, 647-650.
17. Gonzalez, N., Torres, M.-J., Aznar, J., et al. (1999): Molecular analysis of rifampin and isoniazid resistance of Mycobacterium tuberculosis clinical isolates in Seville, Spain. Tuber. Lung Dis., 79, 187-190.
18. Lavender, C., Globan, M., Sievers, A., et al. (2005): Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia. Antimicrob. Agents Chemother., 49, 4068-4074.
19. Cavusoglu, C., Turhan, A., Akinci, P., et al. (2006): Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis isolates. J. Clin. Microbiol., 44, 2338-2342.
20. Aktas, E., Durmaz, R., Yang, D., et al. (2005): Molecular characterization of isoniazid and rifampin resistance of Mycobacterium tuberculosis clinical isolates from Malatya, Turkey. Microb. Drug Resist., 11, 94-99.
21. Caws, M., Duy, P.-M., Tho, D.-Q., et al. (2006): Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam. J. Clin. Microbiol., 44, 2333-2337.
22. Herrera, L., Valverde, A., Saiz, P., et al. (2004): Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical strains isolated in the Philippines. Int. J. Antimicrob. Agents, 23, 572-576.
23. Haas, W.-H., Schilke, K., Brand, J., et al. (1997): Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa. Antimicrob. Agents Chemother., 41, 1601-1603.
24. Shin, S.-S., Naroditskaya, V., Sloutsky, A., et al. (2005): rpoB gene mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis in northern Lima, Peru. Microb. Drug Resist., 11, 26-30.
25. Lee, A.-S., Lim, L-H., Tang, L.-L., et al. (2005): High frequency of mutations in the rpoB gene in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Singapore. J. Clin. Microbiol., 43, 2026-2027.
26. Ma, X., Wang, H., Deng, Y., et al. (2006): rpoB gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China. J. Clin. Microbiol., 44, 3409-3412.
27. Avkan-Oguz, V., Eroglu, C., Guneri, S., et al. (2004): rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis strains isolated in the Aegean region of Turkey. J. Chemother., 16, 442-445.
28. Karahan, Z.-C., Atalay, F., Uzun, M., et al. (2004): Sequence analysis of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Turkey. Microb. Drug Resist., 10, 325-333.